Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 7/2016

01-07-2016 | Pictorial Essay

Endoluminal contrast for abdomen and pelvis magnetic resonance imaging

Authors: Mohit K. Gupta, Gaurav Khatri, April Bailey, Daniella F. Pinho, Daniel Costa, Ivan Pedrosa

Published in: Abdominal Radiology | Issue 7/2016

Login to get access

Abstract

Magnetic resonance (MR) imaging of the abdomen and pelvis can be limited for assessment of different conditions when imaging inadequately distended hollow organs. Endoluminal contrast agents may provide improved anatomic definition and detection of subtle pathology in such scenarios. The available routes of administration for endoluminal contrast agents include oral, endorectal, endovaginal, intravesicular, and through non-physiologic accesses. Appropriate use of endoluminal contrast agents requires a thorough understanding of the clinical indications, available contrast agents, patient preparation, and interaction of the contrast agent with the desired MR imaging protocol. For example, biphasic oral enteric contrast agents are preferred in MR enterography as their signal properties on T1- and T2-weighted imaging allow for evaluation of both intraluminal and bowel wall pathology. In specific situations such as with MR enterography, MR defecography, and accurate local staging of certain pelvic tumors, the use of an endoluminal contrast agent is imperative in providing adequate diagnostic imaging. In other clinical scenarios, the use of an endoluminal contrast agent may serve as an indispensable problem-solving tool.
Literature
1.
Brant WE, Lambert DL (2012) Gastrointestinal tract, peritoneal cavity, and spleen MR imaging. In: Brant WE, de Lange EE (eds) Essentials of body MRI. New York: Oxford University PressCrossRef
2.
Merkle EM, Dale BM, Paulson EK (2006) Abdominal MR imaging at 3T. Magn Reson Imaging Clin N Am 14(1):17–26PubMedCrossRef
3.
Smith EA (2013) Advanced techniques in pediatric abdominopelvic oncologic magnetic resonance imaging. Magn Reson Imaging Clin N Am 21(4):829–841PubMedCrossRef
4.
Mitsumori LM, Bhargava P, Essig M, Maki JH (2014) Magnetic resonance imaging using gadolinium-based contrast agents. Top Magn Reson Imaging : TMRI. 23(1):51–69PubMedCrossRef
5.
Pannu HK, Scatarige JC, Eng J (2009) Comparison of supine magnetic resonance imaging with and without rectal contrast to fluoroscopic cystocolpoproctography for the diagnosis of pelvic organ prolapse. J Comput Assist Tomogr 33(1):125–130PubMedCrossRef
6.
Laghi A, Paolantonio P, Iafrate F, et al. (2002) Oral contrast agents for magnetic resonance imaging of the bowel. Top Magn Reson Imaging : TMRI 13(6):389–396PubMedCrossRef
7.
Kim SH, Lee JM, Lee MW, et al. (2008) Sonography transmission gel as endorectal contrast agent for tumor visualization in rectal cancer. AJR Am J Roentgenol 191(1):186–189PubMedCrossRef
8.
Kane NM, Francis IR, Ellis JH (1989) The value of CT in the detection of bladder and posterior urethral injuries. AJR Am J Roentgenol 153(6):1243–1246PubMedCrossRef
9.
Bodily KD, Fletcher JG, Solem CA, et al. (2006) Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography–correlation with endoscopic and histologic findings of inflammation. Radiology 238(2):505–516PubMedCrossRef
10.
Wold PB, Fletcher JG, Johnson CD, Sandborn WJ (2003) Assessment of small bowel Crohn disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy–feasibility study. Radiology 229(1):275–281PubMedCrossRef
11.
12.
Amzallag-Bellenger E, Oudjit A, Ruiz A, et al. (2012) Effectiveness of MR enterography for the assessment of small-bowel diseases beyond Crohn disease. Radiographics 32(5):1423–1444PubMedCrossRef
13.
14.
Furukawa A, Saotome T, Yamasaki M, et al. (2004) Cross-sectional imaging in Crohn disease. Radiographics 24(3):689–702PubMedCrossRef
15.
16.
Maglinte DD, Siegelman ES, Kelvin FM (2000) MR enteroclysis: the future of small-bowel imaging? Radiology 215(3):639–641PubMedCrossRef
17.
Gourtsoyiannis NC, Papanikolaou N (2005) Magnetic resonance enteroclysis. Semin Ultrasound CT MR 26(4):237–246PubMedCrossRef
18.
Masselli G, Casciani E, Polettini E, Gualdi G (2008) Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn’s disease. Eur Radiol 18(3):438–447PubMedCrossRef
19.
Sinha R, Verma R, Verma S, Rajesh A (2011) MR enterography of Crohn disease: part 2, imaging and pathologic findings. AJR Am J Roentgenol 197(1):80–85PubMedCrossRef
20.
Sinha R, Verma R, Verma S, Rajesh A (2011) MR enterography of Crohn disease: part 1, rationale, technique, and pitfalls. AJR Am J Roentgenol 197(1):76–79PubMedCrossRef
21.
Rieber A, Aschoff A, Nussle K, et al. (2000) MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 10(9):1377–1382PubMedCrossRef
22.
Romero M, Buxbaum JL, Palmer SL (2014) Magnetic resonance imaging of the gut: a primer for the luminal gastroenterologist. Am J Gastroenterol 109(4):497–509; quiz 10.
23.
Kivelitz D, Gehl HB, Heuck A, et al. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy. Acta radiologica (Stockholm, Sweden: 1987). 1999;40(4):429–435.
24.
Small WC, DeSimone-Macchi D, Parker JR, et al. (1999) A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis. J Magn Reson Imaging: JMRI 10(1):15–24PubMedCrossRef
25.
Maccioni F, Bruni A, Viscido A, et al. (2006) MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 238(2):517–530PubMedCrossRef
26.
Karantanas AH, Papanikolaou N, Kalef-Ezra J, Challa A, Gourtsoyiannis N (2000) Blueberry juice used per os in upper abdominal MR imaging: composition and initial clinical data. Eur Radiol 10(6):909–913PubMedCrossRef
27.
Arrive L, Coudray C, Azizi L, et al. (2007) Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography. Journal de radiologie 88(11 Pt 1):1689–1694PubMedCrossRef
28.
Schreyer AG, Golder S, Scheibl K, et al. (2005) Dark lumen magnetic resonance enteroclysis in combination with MRI colonography for whole bowel assessment in patients with Crohn’s disease: first clinical experience. Inflamm Bowel Dis 11(4):388–394PubMedCrossRef
29.
Bakir B, Acunas B, Bugra D, et al. (2009) MR colonography after oral administration of polyethylene glycol-electrolyte solution. Radiology 251(3):901–909PubMedCrossRef
30.
Lauenstein TC, Schneemann H, Vogt FM, et al. (2003) Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 228(1):279–283PubMedCrossRef
31.
Sood RR, Joubert I, Franklin H, Doyle T, Lomas DJ (2002) Small bowel MRI: comparison of a polyethylene glycol preparation and water as oral contrast media. J Magn Reson Imaging 15(4):401–408PubMedCrossRef
32.
Young BM, Fletcher JG, Booya F, et al. (2008) Head-to-head comparison of oral contrast agents for cross-sectional enterography: small bowel distention, timing, and side effects. J Comput Assisted Tomogr 32(1):32–38CrossRef
33.
Van Weyenberg SJ, Meijerink MR, Jacobs MA, et al. (2010) MR enteroclysis in the diagnosis of small-bowel neoplasms. Radiology 254(3):765–773PubMedCrossRef
34.
Masselli G, Polettini E, Casciani E, et al. (2009) Small-bowel neoplasms: prospective evaluation of MR enteroclysis. Radiology 251(3):743–750PubMedCrossRef
35.
Semelka RC, John G, Kelekis NL, Burdeny DA, Ascher SM (1996) Small bowel neoplastic disease: demonstration by MRI. J Magn Reson Imaging 6(6):855–860PubMedCrossRef
36.
Beggs AD, Latchford AR, Vasen HF, et al. (2010) Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 59(7):975–986PubMedCrossRef
37.
Gupta A, Postgate AJ, Burling D, et al. (2010) A prospective study of MR enterography versus capsule endoscopy for the surveillance of adult patients with Peutz-Jeghers syndrome. AJR Am J Roentgenol 195(1):108–116PubMedCrossRef
38.
Masselli G, Polettini E, Laghi F, Monti R, Gualdi G (2014) Noninflammatory conditions of the small bowel. Magn Reson Imaging Clin N Am 22(1):51–65PubMedCrossRef
39.
Horton KM, Kamel I, Hofmann L, Fishman EK (2004) Carcinoid tumors of the small bowel: a multitechnique imaging approach. AJR Am J Roentgenol 182(3):559–567PubMedCrossRef
40.
Pantongrag-Brown L, Buetow PC, Carr NJ, Lichtenstein JE, Buck JL (1995) Calcification and fibrosis in mesenteric carcinoid tumor: CT findings and pathologic correlation. AJR Am J Roentgenol 164(2):387–391PubMedCrossRef
41.
Lohan DG, Alhajeri AN, Cronin CG, Roche CJ, Murphy JM (2008) MR enterography of small-bowel lymphoma: potential for suggestion of histologic subtype and the presence of underlying celiac disease. AJR Am J Roentgenol 190(2):287–293PubMedCrossRef
42.
43.
Froehlich JM, Waldherr C, Stoupis C, Erturk SM, Patak MA (2010) MR motility imaging in Crohn’s disease improves lesion detection compared with standard MR imaging. Eur Radiol 20(8):1945–1951PubMedCrossRef
44.
45.
Tomei E, Diacinti D, Stagnitti A, et al. (2012) MR enterography: relationship between intestinal fold pattern and the clinical presentation of adult celiac disease. J Magn Reson Imaging 36(1):183–187PubMedCrossRef
46.
Masselli G, Picarelli A, Di Tola M, et al. (2010) Celiac disease: evaluation with dynamic contrast-enhanced MR imaging. Radiology 256(3):783–790PubMedCrossRef
47.
Scholz FJ, Afnan J, Behr SC (2011) CT findings in adult celiac disease. Radiographics 31(4):977–992PubMedCrossRef
48.
Shanbhogue AK, Prasad SR, Jagirdar J, et al. (2010) Comprehensive update on select immune-mediated gastroenterocolitis syndromes: implications for diagnosis and management. Radiographics 30(6):1465–1487PubMedCrossRef
49.
Madani G, Katz RD, Haddock JA, Denton CP, Bell JR (2008) The role of radiology in the management of systemic sclerosis. Clin Radiol 63(9):959–967PubMedCrossRef
50.
51.
Rha SE, Ha HK, Lee SH, et al. (2000) CT and MR imaging findings of bowel ischemia from various primary causes. Radiographics 20(1):29–42PubMedCrossRef
52.
Pedrosa I, Levine D, Eyvazzadeh AD, et al. (2006) MR imaging evaluation of acute appendicitis in pregnancy. Radiology 238(3):891–899PubMedCrossRef
53.
Leeuwenburgh MM, Wiarda BM, Wiezer MJ, et al. (2013) Comparison of imaging strategies with conditional contrast-enhanced CT and unenhanced MR imaging in patients suspected of having appendicitis: a multicenter diagnostic performance study. Radiology 268(1):135–143PubMedCrossRef
54.
Pedrosa I, Lafornara M, Pandharipande PV, Goldsmith JD, Rofsky NM (2009) Pregnant patients suspected of having acute appendicitis: effect of MR imaging on negative laparotomy rate and appendiceal perforation rate. Radiology 250(3):749–757PubMedCrossRef
55.
Dewhurst C, Beddy P, Pedrosa I (2013) MRI evaluation of acute appendicitis in pregnancy. J Magn Reson Imaging 37(3):566–575PubMedCrossRef
56.
Berman L, Israel GM, McCarthy SM, Weinreb JC, Longo WE (2007) Utility of magnetic resonance imaging in anorectal disease. World J Gastroenterol 13(23):3153–3158PubMedPubMedCentralCrossRef
57.
O’Malley RB, Al-Hawary MM, Kaza RK, et al. (2012) Rectal imaging: part 2, Perianal fistula evaluation on pelvic MRI–what the radiologist needs to know. AJR Am J Roentgenol 199(1):W43–W53PubMedCrossRef
58.
Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Archives of surgery (Chicago, Ill : 1960). 1998;133(8):894-9.
59.
Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2(8514):996–999PubMedCrossRef
60.
Sauer R, Becker H, Hohenberger W, et al. (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. New Engl J Med 351(17):1731–1740PubMedCrossRef
61.
Beets-Tan RG, Beets GL (2004) Rectal cancer: review with emphasis on MR imaging. Radiology 232(2):335–346PubMedCrossRef
62.
Beets-Tan RG, Beets GL, Vliegen RF, et al. (2001) Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357(9255):497–504PubMedCrossRef
63.
Kaur H, Choi H, You YN, et al. (2012) MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics 32(2):389–409PubMedCrossRef
64.
Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007;243(1):132-9.
65.
66.
Kelvin FM, Maglinte DD, Hale DS, Benson JT (2000) Female pelvic organ prolapse: a comparison of triphasic dynamic MR imaging and triphasic fluoroscopic cystocolpoproctography. AJR Am J Roentgenol 174(1):81–88PubMedCrossRef
67.
Vanbeckevoort D, Van Hoe L, Oyen R, et al. (1999) Pelvic floor descent in females: comparative study of colpocystodefecography and dynamic fast MR imaging. J Magn Reson Imaging 9(3):373–377PubMedCrossRef
68.
Healy JC, Halligan S, Reznek RH, et al. (1997) Patterns of prolapse in women with symptoms of pelvic floor weakness: assessment with MR imaging. Radiology 203(1):77–81PubMedCrossRef
69.
Hetzer FH, Andreisek G, Tsagari C, Sahrbacher U, Weishaupt D (2006) MR defecography in patients with fecal incontinence: imaging findings and their effect on surgical management. Radiology 240(2):449–457PubMedCrossRef
70.
Maglinte DD, Kelvin FM, Fitzgerald K, Hale DS, Benson JT (1999) Association of compartment defects in pelvic floor dysfunction. AJR Am J Roentgenol 172(2):439–444PubMedCrossRef
71.
Mortele KJ, Fairhurst J (2007) Dynamic MR defecography of the posterior compartment: indications, techniques and MRI features. Eur J Radiol 61(3):462–472PubMedCrossRef
72.
Solopova AE, Hetzer FH, Marincek B, Weishaupt D (2008) MR defecography: prospective comparison of two rectal enema compositions. AJR Am J Roentgenol 190(2):W118–W124PubMedCrossRef
73.
Schreyer AG, Paetzel C, Furst A, et al. (2012) Dynamic magnetic resonance defecography in 10 asymptomatic volunteers. World J Gastroenterol 18(46):6836–6842PubMedPubMedCentralCrossRef
74.
Khatri G, Bailey AA, Bacsu C, et al. (2015) Influence of rectal gel volume on defecation during dynamic pelvic floor magnetic resonance imaging. Clin Imaging 39(6):1027–1031PubMedCrossRef
75.
Khatri G (2014) Magnetic resonance imaging of pelvic floor disorders. Top Magn Reson Imaging 23(4):259–273PubMedCrossRef
76.
Maglinte DD, Hale DS, Sandrasegaran K (2013) Comparison between dynamic cystocolpoproctography and dynamic pelvic floor MRI: pros and cons: which is the “functional” examination for anorectal and pelvic floor dysfunction? Abdom Imaging 38(5):952–973PubMedCrossRef
77.
Kelvin FM, Maglinte DD, Hornback JA, Benson JT (1992) Pelvic prolapse: assessment with evacuation proctography (defecography). Radiology 184(2):547–551PubMedCrossRef
78.
Maglinte DD, Kelvin FM, Hale DS, Benson JT (1997) Dynamic cystoproctography: a unifying diagnostic approach to pelvic floor and anorectal dysfunction. AJR Am J Roentgenol 169(3):759–767PubMedCrossRef
79.
Keeling AN, Morrin MM, McKenzie C, et al. (2012) Intravenous, contrast-enhanced MR colonography using air as endoluminal contrast agent: impact on colorectal polyp detection. Eur J Radiol 81(1):31–38PubMedCrossRef
80.
Liebig T, Stoupis C, Ros PR, Ballinger JR, Briggs RW (1993) A potentially artifact-free oral contrast agent for gastrointestinal MRI. Magn Reson Med 30(5):646–649PubMedCrossRef
81.
Okamoto T, Utsunomiya T, Inutsuka S, et al. (1997) The appearance of a normal appendix on barium enema examination does not rule out a diagnosis of chronic appendicitis: report of a case and review of the literature. Surg Today 27(6):550–553PubMedCrossRef
82.
Hosseinzadeh K, Heller MT, Houshmand G (2012) Imaging of the female perineum in adults. Radiographics 32(4):E129–E168PubMedCrossRef
83.
Young P, Daniel B, Sommer G, Kim B, Herfkens R (2012) Intravaginal gel for staging of female pelvic cancers–preliminary report of safety, distention, and gel-mucosal contrast during magnetic resonance examination. J Comput Assist Tomogr 36(2):253–256PubMedCrossRef
84.
Brown MA, Mattrey RF, Stamato S, Sirlin CB (2005) MRI of the female pelvis using vaginal gel. AJR Am J Roentgenol 185(5):1221–1227PubMedCrossRef
85.
Motzer RJ, Mazumdar M, Bacik J, et al. (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17(8):2530–2540PubMed
86.
American Fertility Society. (1988) The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, mullerian anomalies and intrauterine adhesions. Fertil Steril 49(6):944–955CrossRef
87.
Buttram VC Jr, Gibbons WE (1979) Mullerian anomalies: a proposed classification. (An analysis of 144 cases). Fertil Steril 32(1):40–46PubMedCrossRef
88.
Narayanan P, Nobbenhuis M, Reynolds KM, et al. (2009) Fistulas in malignant gynecologic disease: etiology, imaging, and management. Radiographics 29(4):1073–1083PubMedCrossRef
89.
90.
Bazot M, Darai E, Hourani R, et al. (2004) Deep pelvic endometriosis: MR imaging for diagnosis and prediction of extension of disease. Radiology 232(2):379–389PubMedCrossRef
91.
Loubeyre P, Petignat P, Jacob S, et al. (2009) Anatomic distribution of posterior deeply infiltrating endometriosis on MRI after vaginal and rectal gel opacification. AJR Am J Roentgenol 192(6):1625–1631PubMedCrossRef
92.
Fiaschetti V, Crusco S, Meschini A, et al. (2012) Deeply infiltrating endometriosis: evaluation of retro-cervical space on MRI after vaginal opacification. Eur J Radiol 81(11):3638–3645PubMedCrossRef
93.
Blomlie V, Rofstad EK, Trope C, Lien HH (1997) Critical soft tissues of the female pelvis: serial MR imaging before, during, and after radiation therapy. Radiology 203(2):391–397PubMedCrossRef
94.
Leyendecker JR, Barnes CE, Zagoria RJ (2008) MR urography: techniques and clinical applications. Radiographics 28(1):23–46 ((discussion 46–47))PubMedCrossRef
95.
Verswijvel GA, Oyen RH, Van Poppel HP, et al. (2000) Magnetic resonance imaging in the assessment of urologic disease: an all-in-one approach. Eur Radiol 10(10):1614–1619PubMedCrossRef
96.
Zielonko J, Studniarek M, Markuszewski M (2003) MR urography of obstructive uropathy: diagnostic value of the method in selected clinical groups. Eur Radiol 13(4):802–809PubMed
97.
Mee SL, McAninch JW, Federle MP (1987) Computerized tomography in bladder rupture: diagnostic limitations. J Urol 137(2):207–209PubMed
98.
Cass AS (1989) Diagnostic studies in bladder rupture. Indications and techniques. Urol Clin N Am 16(2):267–273
Metadata
Title
Endoluminal contrast for abdomen and pelvis magnetic resonance imaging
Authors
Mohit K. Gupta
Gaurav Khatri
April Bailey
Daniella F. Pinho
Daniel Costa
Ivan Pedrosa
Publication date
01-07-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 7/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0668-0

Other articles of this Issue 7/2016

Abdominal Radiology 7/2016 Go to the issue

OriginalPaper

MRI texture analysis parameters of contrast-enhanced T1-weighted images of Crohn’s disease differ according to the presence or absence of histological markers of hypoxia and angiogenesis

OriginalPaper

Clinical application of navigator-gated three-dimensional balanced turbo-field-echo magnetic resonance cholangiopancreatography at 3 T: prospective intraindividual comparison with 1.5 T

Commentary

Book Review

OriginalPaper

Risk factors for radiation exposure in newly diagnosed IBD patients

OriginalPaper

Accuracy of simple approaches to assessing liver volume in radiological imaging

OriginalPaper

Dual-energy CT of pancreatic adenocarcinoma: reproducibility of primary tumor measurements and assessment of tumor conspicuity and margin sharpness

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits